Balancing access with cost and quality

South African Medical Journal

Volumn 94, Issue 3 I, 2004, Pages 173-174

  Walters, Laubi ^a   Valodia, Biren ^a  

^a Medscheme Pty Ltd   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

COST; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; EDITORIAL; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; LAW; MEDICAL ETHICS; MEDICAL FEE; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; POLITICS; PRESCRIPTION; REIMBURSEMENT; SOCIAL ASPECT;

COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HEALTH CARE REFORM; HUMANS; NATIONAL HEALTH PROGRAMS; POLICY MAKING; QUALITY OF HEALTH CARE; SOUTH AFRICA;

EID: 1642374906     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (2)

1. Rothberg AD, Blignault J, Serfontein T, et al. Experience of a Medicines Reference Pricing model. S Afr Med J 2004; 94: 183-188 (this issue).
2. Kanavos P. Financing pharmaceuticals in transition economies. Croat Med J 1999; 40: 244-259.